Data as of May 17
| +1.08 / +1.06%|
The 19 analysts offering 12-month price forecasts for Alexion Pharmaceuticals Inc have a median target of 120.00, with a high estimate of 132.00 and a low estimate of 88.00. The median estimate represents a +16.62% increase from the last price of 102.90.
The current consensus among 25 polled investment analysts is to Buy stock in Alexion Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.